Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll ...
16h
Delcath Systems markets Hepzato Kit for the treatment of uveal melanoma with unresectable hepatic metastases. Click here to read my analysis of DCTH stock.
Wells Fargo analyst Eva Fortea Verdejo initiated coverage of Merus (MRUS) with an Overweight rating and $91 price target The firm thinks ...
A new treatment for colorectal cancer that has spread to the liver is showing promising results in Dutch medical trials. The ...
Khaleej Times on MSN23h
UAE: This Aromatic Plant May Cure Colon Cancer, Say Scientists From University Of SharjahResearchers from a university in the UAE have discovered that a naturally growing aromatic plant may have the potential to treat colorectal cancer.<p ...
Wells Fargo (NYSE:WFC) initiated coverage on Merus N.V. (NASDAQ:MRUS), currently trading at $41.54 with a market capitalization of $2.84 billion, with an Overweight rating and a price target of $91.00 ...
Zacks.com on MSN15h
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings UpdateThis week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...
KU has nominated four juniors for a prestigious scholarship that recognizes their academic excellence and undergraduate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback